Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Etiology and outcomes in patients with chronic kidney disease and ascites.

View through CrossRef
Abstract Purpose Nephrogenic ascites is an uncommon disorder associated with a grave prognosis. Literature on etiopathogenesis and outcomes are scarce. The objectives were to identify the etiologies of ascites in patients with chronic kidney disease (CKD) and estimate the proportion of nephrogenic ascites and their 90-day mortality. Methods It was a prospective observational hospital-based study. Consecutive patients with CKD admitted to a tertiary care government teaching hospital were recruited. History, examination, investigations, and evaluation of the etiology of ascites were performed. Ascites was classified into high and low serum albumin-ascites gradient types. Patients with ascites were also followed up for three months to monitor for worsening symptoms, further workup (if necessary), and mortality. Results 355 patients were recruited with 72.5% males. 76 were newly diagnosed with CKD. The most common comorbid illnesses were diabetes mellitus and hypertension. 40 patients had ascites with a mean duration of CKD and hemodialysis of 20.9 ± 23.1 and 9.3 ± 15.5, respectively. 13/40 were lost to follow-up. 13 of the remaining 27 who were followed up died. A known etiology was seen in 29/40 (72.5%). The mixed group (any combination of cardiac or liver disease, malignancy, and hypothyroidism) constituted 21/40 patients. 11/40 (27.5%) probably had nephrogenic ascites and 4/11 died during follow-up. Conclusions A tenth of patients with CKD have ascites. A majority of patients with ascites in CKD have an identifiable etiology. The prognosis of ascites in patients with CKD is dismal.
Title: Etiology and outcomes in patients with chronic kidney disease and ascites.
Description:
Abstract Purpose Nephrogenic ascites is an uncommon disorder associated with a grave prognosis.
Literature on etiopathogenesis and outcomes are scarce.
The objectives were to identify the etiologies of ascites in patients with chronic kidney disease (CKD) and estimate the proportion of nephrogenic ascites and their 90-day mortality.
Methods It was a prospective observational hospital-based study.
Consecutive patients with CKD admitted to a tertiary care government teaching hospital were recruited.
History, examination, investigations, and evaluation of the etiology of ascites were performed.
Ascites was classified into high and low serum albumin-ascites gradient types.
Patients with ascites were also followed up for three months to monitor for worsening symptoms, further workup (if necessary), and mortality.
Results 355 patients were recruited with 72.
5% males.
76 were newly diagnosed with CKD.
The most common comorbid illnesses were diabetes mellitus and hypertension.
40 patients had ascites with a mean duration of CKD and hemodialysis of 20.
9 ± 23.
1 and 9.
3 ± 15.
5, respectively.
13/40 were lost to follow-up.
13 of the remaining 27 who were followed up died.
A known etiology was seen in 29/40 (72.
5%).
The mixed group (any combination of cardiac or liver disease, malignancy, and hypothyroidism) constituted 21/40 patients.
11/40 (27.
5%) probably had nephrogenic ascites and 4/11 died during follow-up.
Conclusions A tenth of patients with CKD have ascites.
A majority of patients with ascites in CKD have an identifiable etiology.
The prognosis of ascites in patients with CKD is dismal.

Related Results

Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract Introduction Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
MicroRNA-204 may predict the renal function in patients with chronic kidney disease
MicroRNA-204 may predict the renal function in patients with chronic kidney disease
Background: Chronic kidney disease significantly affects human health by loss of excretory kidney function. MicroRNAs have potential predictive and therapeutic signific...
Etiology and Outcome of Isolated Fetal Ascites
Etiology and Outcome of Isolated Fetal Ascites
OBJECTIVE: To describe the etiology of isolated fetal ascites and associated perinatal outcomes, and to assess the progression of isolated fetal ascites to fetal hydrop...
SPONTANEOUS BACTERIAL PERITONITIS;
SPONTANEOUS BACTERIAL PERITONITIS;
Objectives: To determine the frequency of culture positive (SBP) and culture negative spontaneous bacterial peritonitis (neutrocytic ascites) in cirrhotic population. Period: The s...
Ascitic fluid lipid profile and albumin level
Ascitic fluid lipid profile and albumin level
Serum Ascites Albumin Gradient is the best single test for classifying ascites into portal hypertensive and non–portal hypertensive causes. Like Serum Ascites Albumin Gradient, Ser...
Impact of Chronic Kidney Disease Stage on Lower-extremity Arthroplasty
Impact of Chronic Kidney Disease Stage on Lower-extremity Arthroplasty
End-stage renal disease and dialysis is commonly associated with poor outcomes after joint replacement surgery. The goal of this study was to evaluate postoperative complications i...

Back to Top